Guggenheim reiterates Absci stock rating on endometriosis trial delay
Guggenheim reiterates Absci stock rating on endometriosis trial delay
Similar Posts
Robinhood Opens New Toronto Headquarters, Expands Canadian Workforce | LeapRate
Robinhood Markets has opened a new headquarters in downtown Toronto, marking a deeper commitment to the Canadian market following its acquisition of WonderFi and the launch of the Robinhood Canada app. The new office has the capacity to nearly double the company’s Canadian workforce, which has already grown to more than 200 employees. Johann Kerbrat,…
SEC Charges Private Fund Adviser Adit Ventures Management, Its CEO and Affiliated General Partners in Alleged Fraud
The Securities and Exchange Commission today charged New York-based investment adviser Adit Ventures Management LLC, its CEO Eric Munson, and three affiliated general partners, Adit Ventures LLC; Adit Ventures II LLC; and Adit Ventures III LLC (the General Partners), for allegedly defrauding investors and client funds in connection with investments in pre-IPO shares, such as…
Why Ciena Stock Tanked by Almost 9% on Tuesday
Key Points A significant price target reduction by an analyst was a headwind buffeting Ciena (NYSE: CIEN) on the second trading day of the week. The $100-per-share cut drained optimism for the tech stock, and its price fell by nearly 9% during the day’s trading session. Pre-earnings cut That pundit, TD Cowen’s Joshua Buchalter, now…
